Uncontrolled Hypertension Clinical Trial
— RADIUS-HTNOfficial title:
Renal Artery DenervatIon Using Radial accesS in Uncontrolled HyperTensioN:Non Inferiority Study Comparing Safety and Efficacy of Radio Frequency Renal Denervation Using Iberis Renal Denervation System Via Radial Access Compared With Femoral
Verified date | February 2022 |
Source | Shanghai AngioCare Medical |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Non-inferiority, prospective, multi-center, post-market, randomized 1:1 study in patients with uncontrolled hypertension to compare the safety and efficacy of radio frequency renal denervation using Iberis Renal Denervation System via radial access compared with femoral access.
Status | Not yet recruiting |
Enrollment | 90 |
Est. completion date | July 1, 2023 |
Est. primary completion date | December 1, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. Patient =18 and =75 years old 2. Persistent uncontrolled hypertension defined as Mean of three measurements systolic office >150 mmHg, mean diastolic >80 mmHg, corresponding ambulatory blood pressure mean =140 mmHg (24 hours daytime mean) despite prescription of 2 to 5 anti-hypertensive drugs including one ARB associated to one diuretic or Calcium Channel blocker 3. Renal artery diameter =3 mm (to be assessed during the procedure) 4. Patient eligible for TransFemoral Access and TransRadial Access 5. Patient who understands the trial requirements and the treatment procedures and provides written informed consent Exclusion Criteria: 1. eGFR >45 mL/min/m² 2. Prior renal artery intervention 3. Prior renal transplant 4. Presence of accessory artery (polar artery) supplying more than 20% of renal surface that cannot be treated (diameter <3 mm) during the procedure 5. Patient lacking capacity (i.e. patient suffering from dementia and others) to provide informed consent 6. Patient currently participating in another investigational drug or device study 7. Pregnant or breastfeeding women or those intending to become pregnant before the end of the follow-up 8. Subjects under judicial protection, guardianship or curatorship or subjects deprived of their liberty by judicial or administrative decision |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Shanghai AngioCare Medical |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduction of systolic office systolic blood pressure (OBP) at 3 months. | A routine OBP measurement is defined as the average of 3 readings at 1-minute intervals after a 5-minute resting period in the examination room. | 3 months | |
Secondary | Procedural success | Number of participants with successful completion of the renal denervation procedure via the intended approach | Procedure | |
Secondary | Number of ablations per patient | Number of ablations performed during the procedure for each participants | Procedure | |
Secondary | Procedural duration | Lenght of the procedure | Procedure | |
Secondary | X-Ray exposure | Level of X-Ray exposure | Procedure | |
Secondary | Volume of contrast media | Volume of contrast media use during the procedure | Procedure | |
Secondary | Major vascular events | major hematoma, pseudoaneurysm, arteriovenous fistula, retroperitoneal hematoma, arterial thrombosis, dissection and perforation, distal embolization, femoral nerve injury, local infection and arterial avulsion | Hospitalisation (at least 24hours after procedure) | |
Secondary | Office systolic blood pressure | 3 readings at 1-minute intervals after a 5-minute resting period in the examination room (mmHg) | 6 months | |
Secondary | Office diastolic blood pressure | 3 readings at 1-minute intervals after a 5-minute resting period in the examination room | 3 months and 6 months | |
Secondary | Ambulatory (24 h) blood pressure | Mean (mmHg) | 3 months and 6 months | |
Secondary | Daytime (7:00 am to 10:00 pm) and nighttime (10:00 pm to 7:00 am) BP | Mean (mmHg) | 3 months and 6 months | |
Secondary | Percentage of patients at target BP | Percentage of patient with mean systolic OBP <150 mmHg and min diastolic OBP < 80 mmHg | 3 months and 6 months | |
Secondary | Office heart rate | BPM | 3 months and 6 months | |
Secondary | Ambulatory heart rate | BPM | 3 months and 6 months | |
Secondary | Home BP | 3 measurements in the morning and evening | 7 days prior to baseline/randomization and before every follow-up | |
Secondary | Home heart rate | 3 measurements in the morning and evening | 7 days prior to baseline/randomization and before every follow-up | |
Secondary | Renal function | change of estimated-Glomerular Filtration Rate (eGFR) | 3 months and 6 months | |
Secondary | Renal artery safety | absence of renal re intervention, renal artery stenosis or dissection. This will be assesed during the follow-up by asking patients if he had some adverse events after the procedure. If yes, it will be asked to the patient to detailed and some documents about the event will be collected and adjudicated by a Clinical Event Committee | 6 months | |
Secondary | Changes in medication (DDD Defined Daily Doses) | 3 and 6 months | ||
Secondary | Length of in hospital stay | Discharge (up to 48 hours) | ||
Secondary | Percentage of Vascular Access Site Complication (VASC) | Discharge (up to 48 hours), 3 and 6 months | ||
Secondary | Percentage of Cerebrovascular events | Discharge (up to 48 hours), 3 and 6 months | ||
Secondary | Percentage of Bleeding | Discharge (up to 48 hours), 3 and 6 months | ||
Secondary | Patient satisfaction | Assessed by the Medical Outcomes Study Short Form 36-item health status questionnaire (acute SF-36) and a series of procedure-specific questions | Discharge (up to 48 hours) and 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01966952 -
Evaluation of Safety Mechanisms of Renal Radioablation(RSRA)for Uncontrolled Hypertension
|
N/A | |
Withdrawn |
NCT01939392 -
Rapid Renal Sympathetic Denervation for Resistant Hypertension II
|
Phase 2/Phase 3 | |
Completed |
NCT01699529 -
Multi-electrode Radiofrequency Renal Denervation System Feasibility Study
|
N/A | |
Completed |
NCT01418261 -
SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension
|
N/A | |
Completed |
NCT01635998 -
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
|
N/A | |
Completed |
NCT02674464 -
Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project)
|
N/A | |
Completed |
NCT04809519 -
Integrative Nursing Based Multimodal Interventions for Uncontrolled Hypertensives
|
N/A | |
Completed |
NCT01996033 -
EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension
|
||
Terminated |
NCT01628198 -
Impact of Renal SympAthetic DenerVation on Chronic HypErtension
|
N/A | |
Recruiting |
NCT03221114 -
Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease
|
N/A | |
Completed |
NCT04248530 -
DENEX Renal Denervation in Patients With Uncontrolled Hypertension: Safety Study
|
N/A | |
Recruiting |
NCT06034743 -
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
|
Phase 3 | |
Completed |
NCT02006758 -
Observational Study of the EnligHTN Renal Denervation System in Europe
|
||
Active, not recruiting |
NCT03209154 -
An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment
|
N/A | |
Withdrawn |
NCT05352425 -
Effect of the MobiusHD® in Renal Hemodialysis Subjects With Uncontrolled Hypertension
|
N/A | |
Completed |
NCT05395403 -
Use of Automated Office Blood Pressure Monitoring
|
N/A | |
Recruiting |
NCT05732727 -
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
|
Phase 3 | |
Completed |
NCT02418091 -
Integrated Population Program for Diabetic Kidney Disease
|
N/A | |
Completed |
NCT00888433 -
Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)
|
N/A | |
Recruiting |
NCT05460169 -
Renal Denervation in ADPKD- RDN-ADPKD Study
|
N/A |